首页|血清aPOA1、S100β水平与急性脑梗死患者认知功能及预后的相关性分析

血清aPOA1、S100β水平与急性脑梗死患者认知功能及预后的相关性分析

扫码查看
目的 探讨血清载脂蛋白A1(aPOA1)、中枢神经特异蛋白(S100β)水平与急性脑梗死(ACI)患者认知功能及预后的相关性。方法 回顾性分析2022年6月至2023年6月南阳市中心医院收治的120例ACI患者的临床资料。随访3个月,采用改良Rankin量表评估患者预后,将预后不良患者纳入预后不良组(n=44),将预后良好患者纳入预后良好组(n=76)。患者均接受血清aPOA1、S100β检测,统计两组基线资料,采用双变量相关Pearson(N)分析血清aPOA1、S100β与ACI患者认知功能(MoCA评分)的相关性;采用二元Logistic回归分析血清aPOA1、S100β与ACI患者预后的关系。结果 预后不良组合并高血压、合并糖尿病患者占比高于预后良好组,血清aPOA1水平低于预后良好组、S100β水平高于预后良好组(P<0。05)。预后不良组MoCA评分为(24。64±3。49)分,预后良好组为(27。61±2。01)分,差异有统计学意义(t=5。923,P<0。001)。采用双变量相关Pearson(N)分析结果显示,血清aPOA1与ACI患者MoCA评分呈正相关(r>0,P<0。05),血清S100β与ACI患者MoCA评分呈负相关(r<0,P<0。05)。二元Logistic回归分析结果显示,合并高血压、血清S100β高表达是ACI患者预后不良的危险因素(OR>1,P<0。05),血清aPOA1高表达是ACI患者预后不良的保护因素(OR<1,P<0。05)。结论 血清aPOA1、S100β水平与ACI患者认知功能及预后密切相关,临床可通过检测两者水平评估ACI患者认知功能和预后。
Correlation of serum levels of aPOA1 and S100β with cognitive function and prognosis in acute cerebral infarction patients
Objective To investigate the correlation of serum levels of apolipoprotein A1(aPOA1),central nervous specific protein(S100β)with cognitive function and prognosis in patients with acute cerebral infarction(ACI).Methods The clinical data of 120 ACI patients admitted to Nanyang Central Hospital from June 2022 to June 2023 were retrospectively studied.After 3 months of follow-up,the modified Rankin scale was used to evaluate the prognosis of patients.The patients with poor prognosis were included in the poor prognosis group(n=44),and the patients with good prognosis were included in the good prognosis group(n=76).All patients received serum aPOA1 and S100βdetection.The baseline data of the two groups were statistically analyzed.The correlation of serum aPOA1,S100β with cognitive function(MoCA score)in ACI patients was analyzed by bivariate correlation Pearson(N).Binary Logistic regression was used to analyze the relationship between serum aPOA1,S100β and the prognosis of ACI patients.Results The proportion of patients with hypertension and diabetes in the poor prognosis group was higher than that in the good prognosis group,and the level of serum aPOA1 was lower than that in the good prognosis group,the level of serum S100β was higher than that in the good prognosis group(P<0.05).The MoCA score was(24.64±3.49)points in the poor prognosis group and(27.61±2.01)points in the good prognosis group,the difference was significant(t=5.923,P<0.001).The results of bivariate correlation Pearson(N)analysis showed that serum aPOA1 was positively correlated with MoCA score in ACI patients(r>0,P<0.05),and serum S100β was negatively correlated with MoCA score in ACI patients(r<0,P<0.05).Binary logistic regression analysis showed that hypertension and high expression of serum S100β were risk factors for poor prognosis in ACI patients(OR>1,P<0.05),and high expression of serum aPOA1 was a protective factor for poor prognosis in ACI patients(OR<1,P<0.05).Conclusions The levels of serum aPOA1 and S100β are closely correlated with the cognitive function and prognosis of ACI patients.The cognitive function and prognosis can be evaluated by detecting the levels of aPOA1 and S100β.

Acute cerebral infarctionApolipoprotein A1Central nervous specific proteinCognitive functionPrognosis

张雪芳、秦慧兵、程曼、陈晓静、刘红钊

展开 >

河南省南阳市中心医院老年医学科 473000

急性脑梗死 载脂蛋白A1 中枢神经特异蛋白 认知功能 预后

2024

临床医学
中华医学会河南分会

临床医学

影响因子:0.906
ISSN:1003-3548
年,卷(期):2024.44(4)
  • 14